INSIDER
Texas Alzheimerās patient calls new treatment life-changing
Read full article: Texas Alzheimerās patient calls new treatment life-changingThese past few years are being called a major tipping point in Alzheimer's research. A second treatment has now been approved that targets the underlying cause of Alzheimer's, not just the symptoms.
Parkinsonās Disease: Understanding the signs, symptoms
Read full article: Parkinsonās Disease: Understanding the signs, symptomsApril marks Parkinsonās Disease Awareness Month. Parkinsonās Disease is the second most common age-related neurodegenerative disorder after Alzheimerās disease, and an estimated seven to 10 million people worldwide are diagnosed.
University Health chief medical officer offers answers to most-asked COVID-19 questions amid omicron surge
Read full article: University Health chief medical officer offers answers to most-asked COVID-19 questions amid omicron surgeUniversity Healthās Chief Medical Officer, Dr. Bryan Alsip, answered some of the most-asked questions about COVID-19 and the new omicron variant, which now accounts for a majority of new cases.
Researchers testing investigational drug that may lessen severity of COVID-19 symptoms
Read full article: Researchers testing investigational drug that may lessen severity of COVID-19 symptomsResearchers are testing an investigational drug that may lessen the severity of the symptoms caused by COVID-19.
About 90 people receiving antibody therapy for COVID-19 per day at Freeman Coliseum
Read full article: About 90 people receiving antibody therapy for COVID-19 per day at Freeman ColiseumSAN ANTONIO ā COVID-19 patients in San Antonio are being treated daily at the Freeman Coliseum with antibody therapy. āThereās a small allocation that goes out to the hospitals in the San Antonio area. They all send them to us here at University Health, and we actually mix those products into a solution for IV administration, and those are done at the Freeman Coliseum,ā Mandell said. Nonprofit BCFS Health and Human Servicesā emergency management division is running the operation at the Freeman Coliseum. Vaccines, therapeutics should still be effective against new coronavirus strand, San Antonio doctor says
TearCare wearable device defeats dry eye
Read full article: TearCare wearable device defeats dry eyeCHICAGO, Ill. (Ivanhoe Newswire) ā Burning, tearing, blurry vision -- about 16 million people in the U.S. suffer from dry eye disease. If left untreated, dry eye can cause irreversible damage, but a new wearable device is giving dry eye sufferers immediate relief. But he couldnāt find relief for his dry eye disease and it could sometimes make his work environment uncomfortable. Now a new device is helping dry eye suffers find relief when eye drops donāt work. Itās called TearCare and itās a wearable thermal device that goes over the eye lids.